Myopia Management

ACUVUE® Abiliti Overnight

Treat myopia while your child sleeps with Abiliti Overnight 

Acuvue Abiliti Overnight Package

Abiliti Overnight Lenses - Treat Myopia While They Sleep

ACUVUE® Abiliti Overnight Therapeutic Lenses are the first and only orthokeratology (ortho-k) lenses that are approved for slowing the progression of myopia in children in Canada, while typically providing glasses-free vision during the day.*†1

Girl asleep on her pillow

These lenses have been successfully used in thousands of patients for over 15 years in markets around the world.‡,2 An added benefit of Abiliti Overnight can be that your child can be completely lens-free during the day, meaning they can participate in all activities, including water-sports, without worrying about glasses. †1 

How Do They Work?

When worn overnight, Abiliti Overnight lenses gently and temporarily reshape the surface of your child s eye while they sleep.3-6 This gentle reshaping slows the progression of their myopia and lets them be glasses-free throughout the day. For most individuals, no other vision correction is needed. †1 

What Are the Benefits?

Slow myopia progression

Abiliti Overnight lenses have been shown to slow myopia progression, on average by approximately three prescription steps in just two years^,7-10

Clear glasses-free vision

Typically providing clear vision during the day without the need for eyeglasses or daytime contact lenses.†1

Better performance in school and sports

Kids wearing Abiliti Overnight lenses report better performance in school and sports compared to wearing glasses. ^11

Boost your child's confidence

Higher ratings of appearance, confidence and peer perception are also reported by patients wearing Abiliti Overnight lenses, compared to wearing glasses.^11

Peace of mind

Because parents can help with insertion and removal at home, Abiliti Overnight lenses are a good option for young children.

Girl Painting

Are They Safe And Comfortable To Wear?

In three studies accounting for over 200 patient-years of wear, no serious adverse events (or serious complications) were found with Abiliti Overnight lenses wear.7,9,12 The lenses were designed to keep eyes comfortable with features that help retain moisture and provide high oxygen flow.13 This means you can trust Abiliti Overnight lenses to work safely and comfortably when used as intended.14 

Abiliti 1-Day package

Which Abiliti lens is better for my child?

Abiliti 1-Day lenses are another great option for slowing the progression of myopia. Instead of being worn at night like Abiliti Overnight lenses, they are worn during the day to slow myopia progression and provide vision correction.15 These lenses are thrown away at the end of every day, making cleaning and care simple for kids on the go. An Abiliti prescriber can help you decide which lens is right for your child. 

Abiliti App Platforms

Manage Myopia On-the-Go

Get the SeeAbiliti App to Manage Myopia On-the-Go

As part of our holistic approach to managing myopia, the SeeAbiliti app makes it easy to manage myopia on the go.

App Store

Download from App Store

SeeAbiliti on the App Store

Download now

Google Play

Download from Google play

SeeAbiliti on Google Play

Download now

Sight For Kids® Program

See Your Impact

Every child deserves the gift of clear sight. That's why Johnson & Johnson Vision is proud to support the Sight For Kids® program with our non-profit partner Lions Clubs International Foundation. You can be part of this global effort while enjoying the benefits of Abiliti lenses.  Each annual purchase of an ACUVUE® Abiliti product provides a free comprehensive eye exam to a child in need through Sight For Kids®. An eye exam can detect myopia and early warnings signs and manifestation of over 270 different medical conditions, and is important in maintaining overall eye health.16 To date, almost 48 million students globally have received eye exams, with over 500,000 children in need receiving eyeglasses.17

Female doctor wearing a white coat

Find an eye doctor that specializes in Abiliti lenses for myopia management

Use our easy search tool to find an eye doctor in your local area who can diagnose and treat you.

Man with his daughter on his shoulders


Understand how myopia can impact your child’s vision
and ways to help manage it.


* As of April 19, 2023, based on publicly available resources

† Reducing refractive error up to 4.00D (sphere product) and up to 5.00D and up to 3.50D of astigmatism (toric product)

‡ Previously marketed under Menicon Z Night

^ Compared to single-vision spectacles.


1. Data on File 2023. Instruction for Use (Canada).

2. Data on File 2023. Menicon Initial CE approval 2006 

3. Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez-Ortega R. Short-term changes in ocular biometry and refraction after discontinuation of long-term orthokeratology. Eye Contact Lens. 2014;40(2). 

4. Cho P, Cheung SW. Discontinuation of orthokeratology on eyeball elongation (DOEE). Cont Lens Anterior Eye [Internet]. 2017/01/01. 2017;40(2):82–7. 

5. Lau JK, Vincent SJ, Cheung SW, Cho P. The influence of orthokeratology compression factor on ocular higher-order aberrations. Clin Exp Optom. 2020 Jan; 103(1):123-128.

6. Wan K, Lau JK kit, Cheung SW, Cho P. Refractive and corneal responses of young myopic children to short-term orthokeratology treatment with different compression factors. Contact Lens Anterior Eye. 2020;43(1):65-72. 

7. Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci [Internet]. 2012/09/13.2012;53(11):7077–85. 

8. Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez-Ortega R. Myopia control with orthokeratology contact lenses in Spain: Refractive and biometric changes. Invest Ophthalmol Vis Sci. 2012;53(8). 

9. Chen C, Cheung SW, Cho P. Myopia control using toric orthokeratology (TO-SEE study). Invest Ophthalmol Vis Sci [Internet]. 2013/09/05. 2013;54(10):6510–7. 

10. Walline JJ, Robboy MW, Hilmantel G, Tarver ME, Afshari NA, Dhaliwal DK, Morse CL, Quinn CJ, Repka MX, Eydelman MB. Food and Drug Administration, American Academy of Ophthalmology, American Academy of Optometry, American Association for Pediatric Ophthalmology and Strabismus, American Optometric Association, American Society of Cataract and Refractive Surgery, and Contact Lens Association of Ophthalmologists Co-Sponsored Workshop: Controlling the Progression of Myopia: Contact Lenses and Future Medical Devices. Eye Contact Lens. 2018 Jul;44(4):205-211

11. Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez-Ortega R. Myopia Control With Orthokeratology Contact Lenses in Spain: A Comparison of Vision-Related Quality-of-Life Measures Between Orthokeratology Contact Lenses and Single-Vision Spectacles. Eye & Contact Lens 2013; Volume 39, Number 2. 

12. Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez-Ortega R. Orthokeratology vs. spectacles: adverse events and discontinuations. Optom Vis Sci. 2012 Aug;89(8):1133-9.

13. Data on File 2023. Menicon Internal Documentation

14. Data on File 2023. Instruction For Use. 

15. JJV Data on file, 2021. Efficacy of ACUVUE® Abiliti 1-Day Soft Therapeutic Lenses for Myopia Management: Comparative Claims vs. Single Vision and Dual Focus Lenses. 

16. American Academy of Optometry. Systemic Conditions with Ocular and Visual Manifestations. December 2014.

17. Lions Club International Foundation. Real impact: By the numbers. Available from:


Clear Vision For You

Not actual patients or healthcare professionals. For illustrative purposes only.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Johnson & Johnson Vision, its subsidiaries or affiliates.

No use of any Johnson & Johnson Vision trademark, trade name, or trade dress in this site may be made without the prior written authorization of Johnson & Johnson Vision except to identify the product or services of the company. Third party trademarks are the property of their respective owners.

This website and the information it contains are intended for persons residing in Canada.

© Johnson & Johnson Vision, 2024.